Subscribe for $2

Subscribe for 2 $

ACADIA Pharmaceuticals Aktie News & Pressemeldungen

ACADIA Pharmaceuticals Eulerpool News

ACADIA Pharmaceuticals Eulerpool News

ACADIA Pharmaceuticals Stock News

ACADIA Pharmaceuticals is being monitored by journalists and investors worldwide. We gather the latest ACADIA Pharmaceuticals news here.

October 17 ·
Yahoo
Health Canada approves Acadia’s DAYBUE for Rett syndrome
October 16 ·
Yahoo
Acadia Pharmaceuticals Announces Health Canada Approval of DAYBUE™ (trofinetide) for the Treatment of Rett Syndrome
October 16 ·
Thefly.com
Health Canada grants approval of Acadia's Rett syndrome treatment
October 14 ·
Yahoo
Are ACADIA Pharmaceuticals Inc.'s (NASDAQ:ACAD) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
October 11 ·
TipRanks
Morgan Stanley Sticks to Their Hold Rating for ACADIA Pharmaceuticals (ACAD)
October 10 ·
Thefly.com
Nike upgraded, PayPal downgraded: Wall Street's top analyst calls
October 10 ·
Benzinga
Critical Insights From ACADIA Pharmaceuticals Analyst Ratings: What You Need To Know
October 10 ·
Thefly.com
Acadia Pharmaceuticals reinstated with a Market Perform at Raymond James
October 10 ·
GuruFocus
Baker Bros. Advisors LP's Strategic Acquisition in Talis Biomedical Corp
October 8 ·
Yahoo
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

1

2

1

2

ACADIA Pharmaceuticals Stock Press Releases

ACADIA Pharmaceuticals regularly publishes news on the company's website that are relevant for investors.

Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2